The U.S. Food and Drug Administration today approved the first intraocular lens (IOL) that provides cataract patients with an extended depth-of-focus, which helps improve their sharpness of vision (visual acuity) at near, intermediate and far distances.
from FDA Press Releases RSS Feed https://ift.tt/3076Cj5
via IFTTT
No comments:
Post a Comment